Allopurinol in the treatment of acquired reactive perforating collagenosis*
| Autor: | Martin Inzinger, Hemma Tilz, Cesare Massone, Juergen C. Becker, Antonio Pedro Mendes Schettini, Franz J. Legat |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Male
medicine.medical_specialty Allopurinol Acquired perforating dermatosis Case Report Dermatology Reactive perforating collagenosis Diabetes mellitus Prurigo medicine Humans Aged Hyperparathyroidism Renal insufficiency Chronic business.industry Collagen Diseases Free Radical Scavengers medicine.disease Surgery Diabetes Mellitus Type 1 Kidney Failure Chronic Chronic renal failure Hyperparathyroidism Secondary Secondary hyperparathyroidism business medicine.drug |
| Zdroj: | Anais brasileiros de dermatologia |
| ISSN: | 0365-0596 |
| DOI: | 10.1590/s0365-05962013000100012 |
| Popis: | Acquired reactive perforating collagenosis is a perforating dermatosis usually associated with different systemic diseases, mainly diabetes mellitus and/or chronic renal insufficiency. Different therapies have been tried but treatment is not standardized yet and remains a challenge. In the last few years, allopurinol has been reported as a good therapeutic option for acquired reactive perforating collagenosis. We describe the case of a 73-year-old man affected by acquired reactive perforating collagenosis associated with diabetes type 1 and chronic renal failure with secondary hyperparathyroidism. The patient was successfully treated with allopurinol 100mg once/day p.o.. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|